Lundbeck
HLUN-B.CO
#2493
Rank
A$9.27 B
Marketcap
$9.70
Share price
0.98%
Change (1 day)
28.31%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): $0.53

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is $0.57. In 2022 the company made an earnings per share (EPS) of $0.43 a decrease over its 2021 EPS that were of $0.97.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.5323.24%
2022$0.43-55.47%
2021$0.97-51.83%
2020$2.01-28.01%
2019$2.80-44.08%
2018$5.0051.94%
2017$3.29126.64%
2016$1.45-120.84%
2015-$6.975622.18%
2014-$0.12-110.03%
2013$1.21-28.08%
2012$1.69-52.1%
2011$3.52-1.31%
2010$3.5715.61%
2009$3.09